Angiopro GmbH and Kinepict Health Ltd. Collaborate to Revolutionize Angiography Views
(firmenpresse) - Speyer/Budapest; June 17, 2024 – Angiopro GmbH, a prominent distributor of cardiovascular software and medical products in Europe, and Kinepict Health Ltd., a pioneering developer of advanced imaging technology for blood flow examination, are thrilled to announce their strategic partnership aimed at revolutionizing angiography for both patients and medical professionals. Through this collaboration, Angiopro will exclusively distribute Kinepict’s cutting-edge software technology to hospitals across Europe.
Kinepict’s innovative technology, known as Digital Variance Angiography (DVA), enhances decision-making during endovascular interventions. DVA surpasses the widely used Digital Subtraction Angiography (DSA) by offering a significantly improved signal-to-noise ratio and superior image quality. This technology is applicable in vascular surgery, peripheral interventions and interventional oncology embolization procedures.
The real-time decision support provided by DVA in the operating room enables a substantial reduction in radiation exposure (by at least 70%) and contrast agent volume (by at least 50%), enhancing the safety of interventions for both patients and medical staff. Additionally, this innovation promotes cost efficiencies for hospitals, catheterization labs, and medical physicists globally.
"There are numerous peer-reviewed publications demonstrating the positive impact of DVA on reducing radiation exposure and contrast agent volume, while also enhancing imaging quality. We believe our strategic partnership with Angiopro will significantly advance our mission to benefit both medical professionals and, ultimately, patients," says Szabolcs Osváth, CEO and founder of Kinepict.
"The Kinepict Medical Imaging Tool is revolutionary, delivering crystal-clear images of small vessels and stenoses. We are proud to be the exclusive European distribution partner for this groundbreaking innovation and are excited about its potential to improve patient care," states Benjamin Rieck, CEO of Angiopro GmbH.
Unternehmensinformation / Kurzprofil:
About Angiopro GmbH:
Angiopro GmbH, based in Speyer, Germany, is a leading distributor of cardiovascular medical devices and top-tier software for patient screening pre- and post-cardiovascular interventions.
Website: www.angiopro.de
About Kinepict Health Ltd.:
Kinepict Health Ltd., headquartered in Budapest, is at the forefront of developing innovative imaging technologies designed to improve blood flow examination and endovascular interventions.
Website: www.kinepict.com
Angiopro GmbH
Melanie Braun
Heydenreichstr. 5
67346 Speyer
kontakt(at)angiopro.de
Datum: 17.06.2024 - 11:35 Uhr
Sprache: Deutsch
News-ID 707202
Anzahl Zeichen: 2113
contact information:
Contact person: Melanie Braun
Town:
Speyer
Phone: 06232 291691
Kategorie:
Medical Devices
Typ of Press Release: Cooperation
type of sending: send
Date of sending: 17.06.2024
Diese Pressemitteilung wurde bisher 159 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Angiopro GmbH and Kinepict Health Ltd. Collaborate to Revolutionize Angiography Views"
steht unter der journalistisch-redaktionellen Verantwortung von
Angiopro GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
